Investigating microRNAs as key regulators in a novel communication pathway driving retinal degeneration. [ 1/1/2021 - 12/31/2024 ]

Research Grant

Brief description Age-related macular degeneration (AMD) is the leading cause of blindness in the developed world. The absence of current therapies has resulted in a significant economic burden associated with this debilitating and irreversible disease. This project will investigate the therapeutic potential of the body's own natural delivery vehicles called extracellular vesicles (EV). Along with the molecular cargo contained in EVs we will harness this as a treatment to slow down the progression of AMD.

Funding Amount $1,189,692

Funding Scheme Ideas Grants

Chief Investigator Dr Riccardo Natoli

Notes Ideas Grants